Currently, there are 147.36M common shares owned by the public and among those 136.04M shares have been available to trade.
The company’s stock has a 5-day price change of -2.42% and 16.21% over the past three months. MOMO shares are trading 21.12% year to date (YTD), with the 12-month market performance up to 17.73% higher. It has a 12-month low price of $4.79 and touched a high of $8.19 over the same period. MOMO has an average intraday trading volume of 1.47 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 9.34%, 12.72%, and 25.29% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Hello Group Inc ADR (NASDAQ: MOMO) shares accounts for 70.34% of the company’s 147.36M shares outstanding.
It has a market capitalization of $1.04B and a beta (3y monthly) value of 0.52. The stock’s trailing 12-month PE ratio is 7.72, while the earnings-per-share (ttm) stands at $0.99. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.15% over the week and 3.92% over the month.
Earnings per share for the fiscal year are expected to decrease by -43.33%, and 36.33% over the next financial year. EPS should grow at an annualized rate of -2.30% over the next five years, compared to -8.04% over the past 5-year period.
Looking at the support for the MOMO, a number of firms have released research notes about the stock. JP Morgan stated their Neutral rating for the stock in a research note on June 03, 2024, with the firm’s price target at $13-$6. UBS was of a view on April 28, 2023 that the stock is Buy, while JP Morgan gave the stock Overweight rating on April 14, 2023, issuing a price target of $5- $13. Morgan Stanley on their part issued Equal-Weight rating on February 16, 2023.
